Fox Run Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,978
| Closed | -$270K | – | 1247 |
|
|
2025
Q1 | $270K | Buy |
+30,978
| New | +$270K | 0.04% | 703 |
|
|
2024
Q4 | – | Sell |
-35,849
| Closed | -$809K | – | 1185 |
|
|
2024
Q3 | $809K | Buy |
+35,849
| New | +$809K | 0.18% | 191 |
|
|
2024
Q2 | – | Sell |
-12,255
| Closed | -$460K | – | 1091 |
|
|
2024
Q1 | $460K | Buy |
+12,255
| New | +$460K | 0.1% | 397 |
|
|
2023
Q4 | – | Sell |
-24,736
| Closed | -$1.02M | – | 1029 |
|
|
2023
Q3 | $1.02M | Buy |
24,736
+11,105
| +81% | +$458K | 0.3% | 66 |
|
|
2023
Q2 | $761K | Buy |
+13,631
| New | +$761K | 0.21% | 157 |
|
|
2021
Q1 | – | Sell |
-2,703
| Closed | -$383K | – | 318 |
|
|
2020
Q4 | $383K | Buy |
+2,703
| New | +$383K | 0.77% | 21 |
|